Moon et al.: 'Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination'; mRNA-DNA COVID gene injections is heightening risk of diabetes societally; McCullough warns that
by Paul Alexander
we now face 'lifelong insulin and glucose monitoring as a regrettable consequence of accepting a vaccine.'; carte blanche COVID gene injection not focused on high-risk groups can explode disease
‘Any novel EUA vaccine campaign should be targeted on a small group at the highest risk so large numbers are not exposed to permanent side effects such as insulin-dependent type 1 diabetes.’
SOURCE:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829515/pdf/jkms-38-e12.pdf
‘Report the case of a 56-year-old female patient who developed hyperglycemia after the second dose of COVID-19 mRNA-based vaccination without a prior history of diabetes; uncontrolled hyperglycemia despite administration of oral hyperglycemic agents; initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/ mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment. To our knowledge, this is the first case of the development of type 1 diabetes without diabetic ketoacidosis after mRNA-based COVID-19 vaccination, and is the oldest case of type 1 diabetes development under such circumstances.’
